市场见解

NAB (ASX:NAB) share price gains following digital health claim acquisition

Could this spell the future of the bank’s healthcare payments business?
The post NAB (ASX:NAB) share price gains following digital health claim acquisition appeared first on The Motley Fool Australia. –

The 澳大利亚国家银行 (ASX: NAB) share price is in the green this morning amid news the bank is upping its hold on the health payments space.

NAB’s health payments subsidiary HICAPS – utilised by all of Australia’s private health funds and more than 94,000 health service providers – has proposed to acquire digital health claiming technology business, LanternPay.

At the time of writing, the NAB share price is $29.40, 0.55% higher than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) has gained 0.2% this morning.

Let’s take a closer look at what could be NAB’s next purchase.

NAB share price higher amid new payments purchase

The NAB share price is moving higher on Thursday. Meanwhile, the bank has proposed to acquire a payment technology start-up promising to deliver real-time approvals and faster payments from medical healthcare schemes.

LanternPay is designed to simplify payments processes for medical providers working alongside schemes such as Medicare, workers compensation, and the National Disability Insurance Service (NDIS).

The bank plans to integrate the technology into HICAPS – an acronym for Health Industry Claims and Payments Service.

If all goes to plan, it expects that a new digital HICAPS will be rolled out over the course of this year.

Additionally, according to reporting by the Australian Financial Review, the purchase could lead to a HICAPS app that may see Australians paying for treatments with smartphones at practices without payment terminals.

On the proposed acquisition, NAB’s group executive for business and private bank Andrew Irvine commented:

The healthcare sector is already one of the country’s largest providers of employment, and the fifth largest contributor to Australia’s GDP. Australian healthcare payment systems have been cumbersome – resulting in disjointed payment experiences for patients and complexity for healthcare providers.

Integrating NAB’s HICAPS with LanternPay technology will over time deliver a seamless digital customer experience… Customers who previously might have waited days for a reimbursement from the NDIS for example, will now receive this payment on the spot. For many Australians, this will be an absolute game changer.

LanternPay is owned by platform developer, InLoop. The acquisition is subject to conditions including regulatory approval.

It follows the acquisition of Whitecoat by 银行及金融 - 澳洲联邦银行 (ASX: CBA) last year. The digital healthcare services directory is continuing its pivot towards payment services in the wake of the acquisition.

Right now, the NAB share price is 1.9% higher than it ended in 2021.

The post NAB (ASX:NAB) share price gains following digital health claim acquisition appeared first on The Motley Fool Australia.

Should you invest $1,000 in NAB right now?

Before you consider NAB, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and NAB wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Is Westpac (ASX:WBC) going to be the best big 4 bank for dividends in 2022?

Could this impact the performance of ASX 200 banks more than interest rates in 2022?

What made the NAB (ASX:NAB) share price so appealing in 2021?

These were the top 5 ASX 200 bank shares in 2021

Here’s why this top ASX broker picks NAB shares out of the big four banks

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!